Research Projects

Screening effectiveness of immunotherapeutic drug combinations in genetically engineered mouse models of human-like B-cell malignancies

Research program
Hemato-Oncology
Disease
Lymphoproliferative syndromes

Project information

  • Convocation: 2018-2021
  • Start date: August 31, 2018
  • End date: August 31, 2021
  • Funder: Immunotherapy Centers of Research Excellence (imCORE™) Network (NAV4/2017).
  • Nature of project: International

Need more information?

If you are interested in learning more about our research, please contact us.